ABCC3 p.Ser346Ile
| Predicted by SNAP2: | A: N (78%), C: N (61%), D: N (72%), E: N (87%), F: D (75%), G: N (78%), H: N (66%), I: N (72%), K: N (78%), L: D (63%), M: D (71%), N: N (82%), P: N (61%), Q: N (78%), R: N (66%), T: N (93%), V: N (78%), W: D (63%), Y: D (85%), |
| Predicted by PROVEAN: | A: N, C: N, D: N, E: N, F: D, G: N, H: N, I: N, K: N, L: N, M: N, N: N, P: N, Q: N, R: N, T: N, V: N, W: D, Y: D, |
[switch to compact view]
Comments [show]
None has been submitted yet.
[hide] Expression and localization of hepatobiliary trans... Hepatology. 2005 May;41(5):1160-72. Keitel V, Burdelski M, Warskulat U, Kuhlkamp T, Keppler D, Haussinger D, Kubitz R
Expression and localization of hepatobiliary transport proteins in progressive familial intrahepatic cholestasis.
Hepatology. 2005 May;41(5):1160-72., [PMID:15841457]
Abstract [show]
Mutations of the bile salt export pump (BSEP) or the multidrug resistance P-glycoprotein 3 (MDR3) are linked to impaired bile salt homeostasis and lead to progressive familial intrahepatic cholestasis (PFIC)-2 and -3, respectively. The regulation of bile salt transporters in PFIC is not known. Expression of hepatobiliary transporters in livers of ten patients with a PFIC phenotype was studied by quantitative reverse transcription polymerase chain reaction, Western blotting, and immunofluorescence microscopy. PFIC was diagnosed by clinical and laboratory findings. All patients could be assigned to PFIC-2 or PFIC-3 by the use of BSEP- and MDR3-specific antibodies and by MDR3 gene-sequencing. Whereas in all PFIC-2 patients, BSEP immunoreactivity was absent from the canalicular membrane, in three PFIC-3 livers, canalicular MDR3 immunoreactivity was detectable. Serum bile salts were elevated to 276 +/- 233 and to 221 +/- 109 micromol/L in PFIC-2 and PFIC-3, respectively. Organic anion transporting polypeptide OATP1B1, OATP1B3, and MRP2 mRNA and protein levels were reduced, whereas sodium taurocholate cotransporting polypeptide (NTCP) was only reduced at the protein level, suggesting a posttranscriptional NTCP regulation. Whereas MRP3 mRNA and protein were not significantly altered, MRP4 messenger RNA and protein were significantly increased in PFIC. In conclusion, PFIC-2 may be reliably diagnosed by immunofluorescence, whereas the diagnosis of PFIC-3 requires gene-sequencing. Several mechanisms may contribute to elevated plasma bile salts in PFIC: reduced bile salt uptake via NTCP, OATP1B1, and OATP1B3, decreased BSEP-dependent secretion into bile, and increased transport back into plasma by MRP4. Upregulation of MRP4, but not of MRP3, might represent an important escape mechanism for bile salt extrusion in PFIC.
Comments [show]
None has been submitted yet.
No. Sentence Comment
38 Clinical and Laboratory Parameters of PFIC Patients Patients Clinical Parameters Laboratory Parameters Diagnosis Onset of Symptoms Age at LTx BS (<8 M) ␥GT (<25 U/l) Bilirubin (<1 mg/dL) MDR3-Mutation MDR3- IF BSEP- IF PFIC Type C1 F.A. 4 m 3 y 5 m 47 7 1.3 None detected ϩ - 2 C2 A.A. 3 m 2 y 5 m 144 19 22.6 None detected ϩ - 2 C3 S.H. 3 m 3 y 3 m 616 77 22.7 None detected ϩ - 2 C4 M.D. 6 m 10 y 7 m 160 7 5.4 None detected ϩ - 2 C5 T.A. 6 m 4 y 2 m 414 11 5.4 555 A 3 G/T175A Heterozygous ϩ - 2 C6 M.D. 4 m 7 y 9 m 163 26 11.2 1069 G 3 T/S346I ϩ ϩ 3 C7 S.F. birth 8 y 7 m 299 250 1.9 1069 G 3 T/8346I* ϩ ϩ 3 C8 K.Y. 6 m 3 y 10 m 85 277 0.5 2890 C 3 A/A953D ϩ ϩ 3 C9 K.B. 4 m 3 y 8 m 360 165 1.1 426-432 del† - ϩ 3 C10 B.D. 7 y 11 y 4 m 199 24 20.7 None detected - ϩ 3 NOTE.
X
ABCC3 p.Ser346Ile 15841457:38:587
status: NEW